Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -1149.52% is 30% below its 2-year average of -885.89%, around the middle of its 2-year range (-1675.78%–0.00%).
26.34% below its 12-month average of -909.89%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -853.99%.
OPERATING MARGIN
-1149.52%
OPERATING MARGIN AVG TTM
-909.89%
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-26.34%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 389 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Aktis Oncology, Inc.
Market Cap
$989.05M
Operating Margin
-1149.52%
TTM Avg
-909.89%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$985.79M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-59.79%
Market Cap
$943.26M
Operating Margin
-68.62%
TTM Avg
-63.13%
3Y Avg
-82.91%
5Y Avg
-82.91%
Market Cap
$1.05B
Operating Margin
-6.98%
TTM Avg
-25.06%
3Y Avg
-156.73%
5Y Avg
-114.38%
Market Cap
$922.50M
Operating Margin
-192.08%
TTM Avg
-714.41%
3Y Avg
-506.77%
5Y Avg
-588.71%
Market Cap
$915.95M
Operating Margin
10.63%
TTM Avg
4.11%
3Y Avg
-10.10%
5Y Avg
-5.16%
Market Cap
$903.13M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$867.60M
Operating Margin
-43.83%
TTM Avg
-75.55%
3Y Avg
-37.77%
5Y Avg
-25.18%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aktis Oncology, Inc. (AKTS) | $989.05M | -1149.52% | -909.89% | N/A | N/A |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $985.79M | 0.00% | 0.00% | 0.00% | -59.79% |
| CeriBell, Inc. (CBLL)vs › | $943.26M | -68.62% | -63.13% | -82.91% | -82.91% |
| Teladoc Health, Inc. (TDOC)vs › | $1.05B | -6.98% | -25.06% | -156.73% | -114.38% |
| Arbutus Biopharma Corp (ABUS)vs › | $922.50M | -192.08% | -714.41% | -506.77% | -588.71% |
| Bioventus Inc. (BVS)vs › | $915.95M | 10.63% | 4.11% | -10.10% | -5.16% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $903.13M | 0.00% | 0.00% | 0.00% | 0.00% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $867.60M | -43.83% | -75.55% | -37.77% | -25.18% |
| Apnimed, Inc. (APMD)vs › | $866.15M | N/A | N/A | N/A | N/A |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.12B | 15.66% | 23.78% | 24.92% | 19.79% |
Gross Margin
100.0%
Operating Margin
-1149.5%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -853.99% |
| 2026-03-31 | -703.63% |
| 2025-12-31 | -929.14% |
| 2025-09-30 | -1152.82% |
| 2024-12-31 | -1675.78% |
| 2024-09-30 | 0.00% |
